Fennec Pharmaceuticals, Inc. (FENC)
10.71
+0.08
(+0.75%)
USD |
NASDAQ |
Oct 09, 16:00
10.68
-0.02
(-0.23%)
After-Hours: 20:00
Fennec Pharmaceuticals Price to Book Value : 8.841 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 8.841 |
| October 08, 2026 | 8.775 |
| October 07, 2026 | 8.552 |
| October 06, 2026 | 8.544 |
| October 05, 2026 | 8.766 |
| October 02, 2026 | 8.420 |
| October 01, 2026 | 8.527 |
| September 30, 2026 | 8.791 |
| September 29, 2026 | 8.915 |
| September 28, 2026 | 9.039 |
| September 25, 2026 | 8.754 |
| September 24, 2026 | 8.766 |
| September 23, 2026 | 8.676 |
| September 22, 2026 | 9.088 |
| September 21, 2026 | 9.006 |
| September 18, 2026 | 8.766 |
| September 17, 2026 | 8.898 |
| September 16, 2026 | 8.709 |
| September 15, 2026 | 8.783 |
| September 14, 2026 | 8.849 |
| September 11, 2026 | 9.047 |
| September 10, 2026 | 9.328 |
| September 09, 2026 | 9.617 |
| September 08, 2026 | 10.28 |
| September 04, 2026 | 10.23 |
| Date | Value |
|---|---|
| September 03, 2026 | 10.36 |
| September 02, 2026 | 10.16 |
| September 01, 2026 | 9.930 |
| August 31, 2026 | 10.19 |
| August 28, 2026 | 10.13 |
| August 27, 2026 | 9.716 |
| August 26, 2026 | 10.05 |
| August 25, 2026 | 9.666 |
| August 24, 2026 | 9.410 |
| August 21, 2026 | 9.319 |
| August 20, 2026 | 9.369 |
| August 19, 2026 | 9.798 |
| August 18, 2026 | 9.798 |
| August 17, 2026 | 9.765 |
| August 14, 2026 | 9.674 |
| August 13, 2026 | 9.955 |
| August 12, 2026 | 9.765 |
| August 11, 2026 | 10.55 |
| August 10, 2026 | 9.030 |
| August 07, 2026 | 9.555 |
| August 06, 2026 | 8.948 |
| August 05, 2026 | 8.684 |
| August 04, 2026 | 8.345 |
| August 03, 2026 | 7.916 |
| July 31, 2026 | 7.900 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.98 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.034 |
| Vericel Corp. | 5.545 |
Price to Book Value Related Metrics
| PS Ratio | 5.925 |
| Price | 10.71 |
| Earnings Yield | -1.20% |
| Market Cap | 375.21M |